Targeting the transforming growth factor-beta signalling pathway in metastatic cancer.
Korpal
Manav
M
Department of Molecular Biology, Princeton University, Princeton, NJ, United States.
Kang
Yibin
Y
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology; D016375:Antisense Elements (Genetics) / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000378:metabolism; D003131:Combined Modality Therapy; D018450:Disease Progression; D006801:Humans; D051379:Mice; D009362:Neoplasm Metastasis / Q000188:drug therapy* / Q000503:physiopathology; D009363:Neoplasm Proteins / Q000276:immunology / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000502:physiology
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D016375:Antisense Elements (Genetics); D009363:Neoplasm Proteins; D016212:Transforming Growth Factor beta